Disruptions in this acetylation process may lead to defective oligomerization, disrupted membrane remodeling, impaired GTP hydrolysis, and OPA1 disassembly, all of which are critical for maintaining functional mitochondria and may contribute to the pathogenesis of neurodegenerative diseases such as DOA. The gene discussed is OPA1; the disease is neurodegenerative disease.